Trial NCT01432106

View at ClinicalTrials.gov 
Org. Study IDs: SPP100AUS20T

Last trial update was posted on 2013-11-18

MeSH Interventions

Ramipril Valsartan

MeSH Conditions

Hypertension Metabolic Syndrome Syndrome

Other Conditions


Stopping Reasons

Novartis terminated all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID